Characterization of (2R, 3S)-2-({[4-(2-butynyloxy)phenyl] sulfony1}amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-α converting enzyme

被引:52
|
作者
Zhang, YH
Hegen, M
Xu, J
Keith, JC
Jin, GX
Du, XM
Cummons, T
Sheppard, BJ
Sun, LH
Zhu, Y
Rao, VR
Wang, Q
Xu, WX
Cowling, R
Nickerson-Nutter, CL
Gibbons, J
Skotnicki, J
Lin, LL
Levin, J
机构
[1] Wyeth Res, Dept Inflammat, Cambridge, MA 02140 USA
[2] Wyeth Res, Pearl River, NY 10965 USA
关键词
TNF; selective TACE inhibitor; TMI-2; rheumatoid arthritis;
D O I
10.1016/j.intimp.2004.08.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TNF-alpha converting enzyme (TACE) is a validated therapeutic target for the development of oral tumor necrosis factor-a (TNF-alpha) inhibitors. Here we report the pre-clinical results and characterization of a selective and potent TACE inhibitor, (2R, 3S)-2-({[4-(2-butynytoxy)phenyl]sulfonyl}amino)-N,3-dihydroxybutanamide (M-2), in various in vitro and in vivo assays. TMI-2 is a potent TACE inhibitor in an enzymatic FRET assay (IC50 = 2 nM). It is more than 250-fold selective over MMP-1, 7, -9, -14, and ADAM-10 in vitro. In cell-based assays and human whole blood, TMI-2 inhibits lipopolysaccharide (LPS)-induced TNF secretion with IC50s < 1 uM. Importantly, TMI-2 inhibits the spontaneous release of TNF-alpha in human synovium tissue explants of rheumatoid arthritis patients with an IC50 of 0.8 muM. In vivo, TMI-2 potently inhibits LPS-induced TNF-alpha production in mice (ED50 = 3 mg/kg). In the adjuvant-induced arthritis (AIA) model in rats, treatment with TMI-2 at 30 mg/kg and 100 mg/kg p.o. b.i.d. was highly effective in reducing joint arthritis scores. In a semi-therapeutic collagen-induced arthritis (CIA) model in mice, TM1-2 is highly effective in reducing disease severity scores after oral treatment at 100 mg/kg twice per day. In summary, TMI-2 is a potent and selective TACE inhibitor that inhibits TNF-alpha production and reduces the arthritis scores in pre-clinical models. TMI-2 represents a novel class of TACE inhibitors that may be effective and beneficial in the treatment of rheumatoid arthritis as well as other TNF-mediated inflammatory autoimmune diseases. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1845 / 1857
页数:13
相关论文
共 50 条
  • [41] Stereoselective synthesis of (2R,3S,4S,5R)-trans-3,4-dihydroxy-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran and (2R,3S,4S,5R)-trans-5-ethynyl-2(4-fluorophenoxymethyl)-3,4-O-isopropylidene tetrahydrofuran from mannose diacetonide
    Sharma, GVM
    Punna, S
    Hymavathi, L
    Reddy, NY
    Krishna, PR
    Chorghade, MS
    Ley, SV
    TETRAHEDRON-ASYMMETRY, 2005, 16 (06) : 1135 - 1140
  • [42] Discovery of 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2s,3S,5S,7S)-5-hydroxyadamantan-2-y1)pyrimidine-4-carboxamide (SKI2852): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
    Ryu, Je Ho
    Lee, Jung A.
    Kim, Shinae
    Shin, Young Ah
    Yang, Jewon
    Han, Hye Young
    Son, Hyun Joo
    Kim, Yong Hyuk
    Sa, Joon Ho
    Kim, Jae-Sun
    Lee, Jungeun
    Lee, Jeeyeon
    Park, Hyeung-geun
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (22) : 10176 - 10189
  • [43] Synthesis of (2R,3S)-2-(3,4-Dihydroxy phenyl)chroman-3,5,7-triol Derivative Boron Compounds: Antioxidant, Enzyme, Antimicrobial, and Antibiofilm Activities
    Pasa, Salih
    Atlan, Metin
    Temel, Hamdi
    Ertas, Abdulselam
    Yabas, Ebru
    Dincer, Emine
    CHEMISTRYSELECT, 2025, 10 (07):
  • [44] Asymmetric synthesis of (2R,3S)-4-halo-3-benzyloxy-2-(N-methoxycarbonyl-N-benzylamino)butyronitriles as precursors for the synthesis of β-hydroxy-α-amino acids
    Badorrey, R
    Cativiela, C
    Díaz-de-Villegas, MD
    Gálvez, JA
    TETRAHEDRON-ASYMMETRY, 2000, 11 (04) : 1015 - 1025
  • [45] Improved synthesis of (4S)-4-[(1S,2R)1,2-epoxybut-3-enyl]-2-phenyl-2-oxazoline, a key intermediate for sphingolipids
    Murakami, T
    Shimizu, T
    SYNTHETIC COMMUNICATIONS, 1997, 27 (24) : 4255 - 4264
  • [46] BETA-1-SELECTIVE ADRENOCEPTOR ANTAGONISTS IN THE 2-[4-[3-(SUBSTITUTED-AMINO)-2-HYDROXYPROPOXY]PHENYL]IMIDAZOLE CLASS
    BALDWIN, JJ
    CHRISTY, ME
    DENNY, GH
    FREEDMAN, MB
    HABECKER, CN
    LYLE, PA
    PONTICELLO, GS
    VARGA, SL
    GROSS, DM
    SWEET, CS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 189 (APR-): : 46 - MEDI
  • [47] (2R*,3R*,6S*)-N,6-Bis(4-fluorophenyl)-2-(4-hydroxy-phenyl)-3,4,5,6-tetrahydro-2H-pyran-3-carboxamide
    Swamy, GYSK
    Ravikumar, K
    Wadhwa, LK
    Saxena, R
    Singh, S
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O3608 - O3610
  • [48] An Efficient and Scalable Synthesis of (2R,αS)-3,4-Dihydro-2-[3-(1, 1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-α-(trifluoromethyl)-1(2H)-quinolineethanol: A Potent CETP Inhibitor
    Wang, Aihua
    Zhang, Yan
    Lu, Songfeng
    Murray, William V.
    Kuo, Gee-Hong
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2010, 47 (06) : 1406 - 1410
  • [49] BETA-1-SELECTIVE ADRENOCEPTOR ANTAGONISTS - EXAMPLES OF THE 2-[4-[3-(SUBSTITUTED AMINO)-2-HYDROXYPROPOXY]PHENYL]IMIDAZOLE CLASS .2.
    BALDWIN, JJ
    CHRISTY, ME
    DENNY, GH
    HABECKER, CN
    FREEDMAN, MB
    LYLE, PA
    PONTICELLO, GS
    VARGA, SL
    GROSS, DM
    SWEET, CS
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (06) : 1065 - 1080
  • [50] Syntheses and Antimycobacterial Activities of [(2S,3R)-2-(Amino)-4-(Arenesulfonamido)-3-Hydroxy-1-Phenylbutane Derivatives
    Moreth, Marcele
    Gomes, Claudia R. B.
    Lourenco, Maria C. S.
    Soares, Rodrigo P.
    Rocha, Marcele N.
    Kaiser, Carlos R.
    de Souza, Marcus V. N.
    Wardell, Solange M. S. V. N.
    Wardell, James L.
    MEDICINAL CHEMISTRY, 2014, 10 (02) : 189 - 200